| 2013 |
A homozygous missense mutation p.Arg183Trp in UQCRC2 disrupts the hydrophobic core at the subunit interface of the core protein II homodimer (structural modeling), causing mitochondrial Complex III deficiency and impaired assembly of the CI/CIII/CIV supercomplex, as demonstrated in patient fibroblasts. |
Whole-exome sequencing, structural modeling, in vitro biochemical assays in patient fibroblasts (CIII activity, supercomplex assembly) |
Human mutation |
High |
23281071
|
| 2021 |
A homozygous missense mutation p.Gly222Ala in UQCRC2 impairs specific protein-protein interactions, leading to accumulation of CIII subassemblies that lack UQCRC1, UQCRC2, and UQCRFS1. Mutant UQCRC2 fails to interact with UQCRC1, causing degradation of both subunits by mitochondrial CLPP protease. This reduces available CIII for supercomplex formation, diminishes CI levels, and impairs electron flux between CI and CIII. Ectopic wild-type UQCRC2 expression rescued maximal respiration rate in patient cells. |
Patient fibroblast biochemistry, Western blot for subunit and subassembly levels, CLPP protease quantification, respiratory flux measurements, ectopic wild-type UQCRC2 rescue experiment |
Biochimica et biophysica acta. Molecular basis of disease |
High |
33865955
|
| 2021 |
AMPK indirectly upregulates UQCRC2 protein levels by activating NFE2L2/NRF2, which enhances UQCRC2 gene transcription. UQCRC2 knockdown impairs mitophagy, while UQCRC2 overexpression increases mitophagy and attenuates alcohol-induced liver injury, defining an AMPK–NFE2L2–UQCRC2 signaling axis in hepatic mitophagy regulation. |
UQCRC2 knockdown/overexpression in hepatocytes, RNA-seq, chromatin immunoprecipitation (ChIP) assay, luciferase reporter assay, co-immunoprecipitation, mitophagy flux measurements (LC3, PINK1/Parkin), OCR measurement |
Autophagy |
Medium |
33719895
|
| 2021 |
UQCRC2 is required for PINK1/Parkin-mediated mitophagy in ethanol-exposed hepatocytes; UQCRC2 knockdown reduces the capacity to clear impaired mitochondria, increases mitochondrial ROS, and exacerbates MLKL-mediated necroptosis by sustaining the ROS-dependent positive feedback between p-MLKL and RIPK1/RIPK3. |
In vitro UQCRC2 knockdown in ethanol-treated hepatocytes, mitophagy flux assays, mitochondrial ROS measurement, Western blot for RIPK1/RIPK3/MLKL phosphorylation, in vivo UQCRC2 knockdown |
Free radical biology & medicine |
Medium |
34774698
|
| 2025 |
SIRT5-mediated desuccinylation of UQCRC2 at lysine 250 promotes translocation of UQCRC2 from the cytoplasm to mitochondria, enhancing mitochondrial respiratory complex III activity, increasing mitochondrial ROS, accelerating cellular senescence, and inhibiting osteogenic differentiation of BM-MSCs. |
Succinylation proteomics, Co-immunoprecipitation, SIRT5 overexpression/knockdown, OCR measurement, mitochondrial ROS assay, osteogenic differentiation assays (Alizarin red staining, Western blot for Runx2/osteocalcin) |
Cellular signalling |
Medium |
39892725
|
| 2024 |
UQCRC2 plays a role in dimerization of mitochondrial Complex III; novel compound heterozygous variants (p.Gly397Arg and p.Phe146Ser) cause Complex III deficiency with metabolic phenotype, confirming the structural requirement of UQCRC2 for CIII function. |
Whole-exome sequencing, clinical biochemistry (Complex III activity), variant pathogenicity assessment |
Cold Spring Harbor molecular case studies |
Low |
37709555
|
| 2026 |
TDP-43 regulates alternative splicing of the nuclear-encoded UQCRC2 transcript; TDP-43 knockdown causes aberrant mis-splicing of UQCRC2 mRNA leading to decreased UQCRC2 protein, selective disruption of Complex III activity, and impaired mitochondrial morphology and respiratory capacity. This was observed in both HEK293T and SH-SY5Y cells. |
TDP-43 knockdown, transcript analysis (alternative splicing), OXPHOS complex assembly assay, mitochondrial morphology imaging, respiratory capacity measurement |
Biology direct |
Medium |
41761273
|
| 2024 |
UQCRC2 knockdown in 3D-cultured SCAPs increases mitochondrial ROS, decreases mitochondrial membrane potential, and reduces the oxygen consumption rate for oxidative phosphorylation, accelerating cellular senescence, demonstrating that UQCRC2-mediated mitochondrial homeostasis is required for delaying senescence. |
UQCRC2 knockdown in 3D-cultured SCAPs, mitochondrial ROS measurement, mitochondrial membrane potential assay, OCR measurement, senescence assays |
Journal of translational medicine |
Medium |
39707408
|
| 2025 |
SLC25A28 (mitochondrial iron transporter) specifically suppresses UQCRC2 expression downstream of baicalin treatment, disrupting Complex III electron transport, increasing mitochondrial ROS, and triggering ferroptosis in colorectal cancer cells. UQCRC2 knockdown exacerbated ferroptosis, while UQCRC2 overexpression conferred protection, confirming UQCRC2 as a functional mediator in the SLC25A28–UQCRC2–ETC ferroptosis axis. |
Quantitative proteomics, genetic knockdown/overexpression, pharmacological inhibition, xenograft models, lipid peroxidation and glutathione/GPX4 assays |
Free radical biology & medicine |
Medium |
41456814
|
| 2013 |
UQCRC2 is required for normal sperm function; reduced UQCRC2 protein levels in mouse spermatozoa (induced by nutlin-3a) are associated with decreased intracellular ATP production, impaired sperm motility, reduced capacitation and acrosome reaction, and poor fertilization rates in vitro. |
In vitro mouse spermatozoa treatment with nutlin-3a, Western blotting for UQCRC2, ATP assay, CASA (computer-assisted sperm analysis), CTC staining, IVF |
PloS one |
Low |
24130818
|
| 2017 |
The same UQCRC2 p.Arg183Trp mutation identified in the first family causes isolated Complex III deficiency when present in a second unrelated patient, confirming that this residue is functionally essential for CIII activity. |
Sanger sequencing, clinical biochemistry (Complex III activity measurement in patient tissue) |
Journal of human genetics |
Medium |
28275242
|